PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
PineTree Therapeutics engages in the development of disruptive therapies in Oncology and Immuno-oncology.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jun 7, 2022 | Series A | $23.50M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
SGI Venture Capital | — | Series A |
JCurve Investment | — | Series A |